期刊文献+

血浆网膜素-1水平与结直肠癌的相关性研究 被引量:4

Correlation between plasma omentin-1 levels and colorectal cancer
下载PDF
导出
摘要 目的探讨血浆脂肪因子网膜素-1(omentin-1)水平和结直肠癌(CRC)的相关关系。方法选取经术后病理检查明确诊断为CRC的患者42例(肿瘤组)和接受纤维结肠镜检查为正常的健康志愿者42例(对照组),两组间年龄、性别均匹配。采用ELISA法测定肿瘤组以及对照组空腹血浆omentin-1水平。结果与对照组相比,肿瘤组患者血浆omentin-1水平明显升高(P<0.05)。Pearson相关分析显示,血浆omentin-1与高密度脂蛋白胆固醇(HDL-C)呈正相关(r=0.57,P<0.01),与血清三酰甘油(TG)、空腹胰岛素(FINS)、腰臀比(WHR)、稳态模型胰岛素抵抗指数(HOMAIR)均呈负相关(r=-0.668、-0.493、-0.395、-0.371,P<0.05)。多元逐步线性回归分析显示,TG、HDL-C、WHR为CRC患者血浆omentin-1的影响因素。结论血浆omentin-1水平可能与CRC发生有关。 Objective To investigate the relationship between plasma adipocytokine omentin-1 levels and colorectal cancer ( CRC) . Methods This study was conducted among 42 patients with pathologically diagnosed CRC after operation as the case group, and 42 healthy subjects who underwent total colonoscopy because of a voluntary health check-up as the control group. The above two groups were matched between age and sex. After participants had fasted overnight,their blood samples were collected. Fasting plasma omentin-1 was measured using ELISA methods. Results The omentin-1 levels in patients with CRC were significantly higher than in controls ( P 〈0. 05 ) . Spearman correlation analysis showed that plasma omentin-1 was positively correlated with high density lipoprotein cholosterol (HDL-C) (r=0. 57,P〈0. 01),and negatively correlated with serum triglyceride(TG), fsating insulin (FINS), waist hip ratio(WHR), HOMA model insulin resistance index(HOMA-IR) (r = -0. 668,-0. 493,-0. 395,-0. 371,respectively, P〈0. 05). Multiple stepwise regression analysis showed that TG, HDL-C, WHR were the influencing factors of plasma omentin-1 in CRC patients. Conclusion The plasma omentin-1 level may correlate with the development of CRC.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第1期75-78,共4页 Acta Universitatis Medicinalis Anhui
基金 中华医学会临床科研专项基金(编号:12020320322) 安徽省科技厅科技攻关项目(编号:1206C0805034)
关键词 脂肪因子 网膜素-1 结直肠癌 adipocytokine omentin-1 colorectal cancer
  • 相关文献

参考文献16

  • 1Kant P,Hull M A.Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer[J].Nat Rev Gastroebterol Hepatol,2011,8(4):224-38.
  • 2Kang H W,Kim D,Kim H J,et al.Visceral obesity and insulinresistance as risk factors for colorectal adenoma:across-sectional,case-control study[J].Am J Gastroenterol,2010,105(1):178-87.
  • 3Chen M W,Ye S,Zhao L L,et al.Association of palma total andhigh-molecular-weight adiponectin with risk of colorectal cancer:an observational study in Chinese male[J].Med Oncol,2012,29(5):3129-35.
  • 4Chen M,Wang Y,Li Y,et al.Association of plasma visfatin withrisk of colorectal cancer:An observational study of Chinese pa-tients[J]. Asia Pac J Clin Oncol,2013:[Epub ahead of print].
  • 5Kumor A,Daniel P,Pietruczuk M,et al.Serum leptin,adipone-ctin,and resistin concentration in colorectal adenoma and carcino-ma(CC)patients[J].Int J Colorectal Dis,2009,24(3):275-81.
  • 6Fazeli M S,Dashti H,Akbarzadeh S,et al.Circulating levels of no-vel adipocytokines in patients with colorectal cancer[J].Cytokine,2013,62(1):81-5.
  • 7Joshi R K,Lee S A.Obesity related adipokines and colorectalcancer:a review and meta-analysis[J].Asian Pac J Cancer Prev,20i4,15(l):397-405.
  • 8Yang R Z,Lee M J,Hu H,et aL Identification of omenlin as a no-vel depot-specific adipokine in human adipose tissue:possible rolein modulating insulin action[J].Am J Physiol Endocrinol Metab,2006,290(6):E1253-61.
  • 9Yang M H,Rampal S,Sung J,et al.The association of serum lip-ids with colorectal adenomas[J].Am J Gastroenterol,2013,108(5):833-41.
  • 10叶帅,陈明卫,李永翔,余昌俊,汪圣毅.胰岛素抵抗与结直肠癌关系的临床研究[J].中国慢性病预防与控制,2012,20(4):378-381. 被引量:5

二级参考文献28

  • 1Sayaka Otake,Hiroaki Takeda,Shoichiro Fujishima,Tadahisa Fukui,Tomohiko Orii,Takeshi Sato,Yu Sasaki,Shoichi Nishise,Sumio Kawata.Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer[J].World Journal of Gastroenterology,2010,16(10):1252-1257. 被引量:14
  • 2夏菲,韩萍.结直肠癌发病机制研究进展:胰岛素抵抗的作用[J].胃肠病学,2007,12(3):176-178. 被引量:5
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 4Kong AP,Chan JC. Cancer risk in type 2 diabetes [J]. Curt Diab Rep,2012,12(4) :325 - 328.
  • 5Onitilo AA, Engel JM, Glurich I, et al. Diabetes and cancer : risk, survival, and implications for screening [ J ]. Cancer Causes Con- trol,2012,23 ( 6 ) : 967 - 981.
  • 6Chang CH, Lin JW, Wu LC,et al. Oral insulin secretagogues,insu- lin, and cancer risk in type 2 diabetes mellitus [ J ]. J Clin Endocri- nol Metab ,2012,97 ( 7 ) : 1170 - 1175.
  • 7Taubes G. Cancer research,cancer prevention with a diabetes pill? [ J ]. Science,2012,335 (6064) :29.
  • 8Austin MA,Kuo E,Van Den Eeden SK, et al. Family history of di- abetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study Cancer [ J ]. Cancer Epidemiol Biomarkers Prey ,2013,22(10) :1913 - 1917.
  • 9中华医学会糖尿病分会.中国2型糖尿病防治指南(2010版)[J].中国糖尿病杂志,2012,20(1):1-37.
  • 10Chen MW, Ye S, Zhao LL, et al. Association of plasma total and high-molecular-weight adiponeetin with risk of eoloreetal cancer: an observational study in Chinese male[J].Med Oneol, 2012,29 (5) :3129 -3135.

共引文献10

同被引文献10

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部